BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UCLA Communication - ECPv6.15.12//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://comm.ucla.edu
X-WR-CALDESC:Events for UCLA Communication
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20180111T164500
DTEND;TZID=America/Los_Angeles:20180111T174500
DTSTAMP:20260901T164901
CREATED:20201001T185306Z
LAST-MODIFIED:20201001T185306Z
UID:3491-1515689100-1515692700@comm.ucla.edu
SUMMARY:Dean's Distinguished Speaker Series
DESCRIPTION:Martine Rothblatt (B.A. ’77\, J.D./MBA ’81)Chairwoman & CEOUnited TherapeuticsThursday\, January 11\, 20184:45 – 5:45 p.m.Korn Convocation HallUCLA Anderson School of ManagementJoin Dean Judy Olian in hosting Martine Rothblatt\, Chairwoman & CEO\, United Therapeutics. Rothblatt was the co-founder of Sirius Satellite Radio in 1990. After she left the company prior to its 1993 IPO\, her daughter was diagnosed with pulmonary arterial hypertension\, prompting Rothblatt’s move into biotech. She founded United Therapeutics in 1996\, which now sells five FDA-approved pills to help people with the disease. The publicly traded company is now experimenting with pig cloning and genetic modification to create lung transplants. In September 2017\, Forbes named Rothblatt as one of the 100 Greatest Living Business Minds of the past 100 years.About Martine RothblattMartine Rothblatt is Chairwoman & CEO of United Therapeutics\, a company she started to save the life of one of her daughters. She leads efforts to create novel drug-device combination products\, to decode the pharmacogenomic properties of medicines and to manufacture an unlimited supply of transplantable organs. She previously created and led Sirius XM as its Chairman & CEO\, and launched other satellite systems for navigation and international television broadcasting.In the field of aviation her Sirius XM satellite system enhances safety with real-time digital weather information to pilots in flight nationwide\, and she designed the world’s first electric helicopter\, subsequently setting dual-pilot speed\, altitude and endurance records in it. Dr. Rothblatt also led the first efforts to create transgender health law standards\, and to protect privacy and autonomy rights in genetic information via an international treaty.She has Bachelor’s (Communications Studies\, Summa Cum Laude)\, JD and MBA degrees from UCLA\, and a Ph.D. in Medical Ethics from the Royal London School of Medicine & Dentistry. Her patented inventions cover aspects of satellite radio\, prostacyclin biochemistry and cognitive software. Dr. Rothblatt’s recent books are on xenotransplantation (Your Life or Mine)\, non-binary gender identity (Transgender to Transhuman) and cyberethics (Virtually Human).Instagram: @transbinary\, Twitter: @skybiomeHave a question for Martine Rothblatt? #AskRothblatt
URL:https://comm.ucla.edu/event/deans-distinguished-speaker-series/
END:VEVENT
END:VCALENDAR